首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1673046

特種注射劑市場：依藥物類型、應用、通路和地區分類

Specialty Injectable Market, By Drug Type, By Application, By Distribution Channel, By Geography

出版日期: 2025年02月10日 | 出版商:

Coherent Market Insights | 英文 176 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球特種注射劑市場規模估計為 626.2 億美元，預計到 2032 年將達到 1,221 億美元，2025 年至 2032 年的複合年成長率為 10.0%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	626.2億美元
效能資料	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	10.00%	2032年價值預測	1221億美元

數字。 2025 年各地區特種注射劑市場佔有率（%）

特殊注射劑是指透過皮下、靜脈、肌肉或玻璃體內注射給藥的注射藥物療法。這些注射劑用於多種治療領域，包括腫瘤學、風濕病學、心血管病、自體免疫和中樞神經系統疾病。近年來，生技藥品和標靶治療藥物的進步以及全球老齡人口的增加推動了對特殊注射劑的需求。此外，複雜的藥物輸送機制和療效更高的下一代藥物-設備組合產品的出現正在導致採用率的提高。一些製藥公司正在大力投資專門的藥物研發和生物相似藥開發，以滿足新興市場日益成長的需求。

市場動態

全球專業注射劑市場的成長受到慢性病患病率上升、易患各種疾病的老年人口成長、醫療保健支出增加以及技術進步的推動。此外，創新生技藥品的出現和基因療法的採用正在創造有利可圖的機會。然而，專科藥物的高研發成本、嚴格的監管途徑以及複雜的冷鏈供應鏈管理帶來了重大挑戰。市場面臨重磅藥物專利到期的威脅。製藥公司正專注於透過合作和收購來擴大產品平臺，這可能會推動預測期內的市場成長。

本研究的主要特點

本報告對全球特種注射劑市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。

它還強調了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。

全球專業注射劑市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數列出的。

本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

全球專業注射劑市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員將透過用於分析全球專業注射劑市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 62.62 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.00%	2032 Value Projection:	USD 122.10 Bn

Specialty injectable refers to injectable drug therapies that are administered through sites such as subcutaneous, intravenous, intramuscular, and intravitreal routes. These injectables are used across several therapeutic areas including oncology, rheumatology, cardiovascular, autoimmune, and central nervous system indications. Advancements in biologics and targeted therapies along with growing geriatric population globally have boosted demand for specialty injectables in recent years. Moreover, advent of complex drug delivery mechanisms and next-generation drug-device combination products with enhanced efficacy have led to its increased adoption rate. Several pharmaceutical companies are investing heavily in specialized drug discovery and development of biosimilars to cater to growing needs in the market.

Market Dynamics

Global specialty injectable market growth is driven by rising incidence of chronic diseases, growing geriatric population prone to various illnesses, increase in healthcare spending, and technological progressions. Furthermore, emergence of innovative biologics and adoption of gene therapy has created lucrative opportunities. However, high development costs of specialty drugs, stringent regulatory pathways, and complex Cold supply chain management pose significant challenges. The market faces threats from patent expiries of blockbuster drugs. Pharmaceutical players are focusing on widening their product pipelines through research collaborations as well as acquisitions, and this can drive the market growth over the forecast period.

Key features of the study

This report provides in-depth analysis of the global specialty injectable market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global specialty injectable market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Novartis AG, Lupin, Mylan N.V., Par Pharmaceutical, Hikma Pharmaceutical PLC, Sagent Pharmaceuticals, Inc., Biogen, Dr. Reddy's Laboratories Ltd., Amgen Inc., AstraZeneca, Sun Pharmaceutical Industries Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global specialty injectable market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global specialty injectable market

Market Segmentation

By Drug Type Insights (Revenue, USD, 2020 - 2032)
- Small Molecule Drugs
- Biologics
By Application Insights (Revenue, USD, 2020 - 2032)
- Oncology
- Cardiovascular Diseases
- Infectious Diseases
- Autoimmune Disorders
- Others
By Distribution Channel Insights (Revenue, USD, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer, Inc.
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Lupin
- Mylan N.V.
- Par Pharmaceutical
- Hikma Pharmaceutical PLC
- Sagent Pharmaceuticals, Inc.
- Biogen
- Reddy's Laboratories Ltd.
- Amgen Inc.
- AstraZeneca
- Sun Pharmaceutical Industries Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Specialty Injectable Market, By Drug Type
- Specialty Injectable Market, By Application
- Specialty Injectable Market, By Distribution Channel
- Specialty Injectable Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Market Trends

4. Specialty Injectable Market, By Drug Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Small Molecule Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Specialty Injectable Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Autoimmune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Specialty Injectable Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Specialty Injectable Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021- 2032, (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lupin
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Par Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hikma Pharmaceutical PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sagent Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biogen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Reddy's Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies